Condyloma Acuminatum
📧 Sign up to get email alerts when something new happens for Condyloma Acuminatum.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2023-11-22FDA Approved: PODOFILOX — Supplemental Application (Padagis US LLC)
The FDA approved a supplemental application for Podofilox by Padagis US LLC, updating the product labeling through a supplemental filing.
-
CLINICAL_TRIALS trial_result · 2018-07-20Clinical Trial Update: A Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of Twice Daily Topical Applications of AP611074 5% Gel for up to 16 Weeks in Condyloma Patients [Phase 2]
A Phase 2 trial evaluating safety, tolerability, pharmacokinetics and efficacy of twice-daily AP611074 5% gel in condyloma patients over up …
-
CLINICAL_TRIALS trial_result · 2016-08-19Clinical Trial Update: Safety Study of Multikine in the Treatment of Perianal Warts [Phase 1]
Phase 1 safety study of Multikine for treating perianal warts has been terminated.
-
CLINICAL_TRIALS withdrawal · 2015-06-19Clinical Trial Update: Broad Spectrum HPV Vaccine Tolerability, Immunogenicity, and Efficacy Study (V502-003) [Phase 2]
A Phase 2 study of a broad-spectrum HPV vaccine (V502-003) evaluating tolerability, immunogenicity, and efficacy has been withdrawn. The stu…
-
CLINICAL_TRIALS trial_result · 2015-03-12Clinical Trial Update: Recurrent and Nonrecurrent Condyloma Treatment [Phase 2, Phase 3]
A Phase 2/Phase 3 clinical trial evaluating a treatment for recurrent and nonrecurrent genital warts (condyloma acuminatum) has been termina…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-08-15Clinical Trial Update: Safety and Efficacy Study to Test Topical AS101 for External Genital Warts [Phase 1, Phase 2]
Phase 1/2 safety and efficacy trial evaluating topical AS101 for external genital warts has completed.
-
FDA approval · 2011-04-15FDA Approved: IMIQUIMOD — Original Application (Sun Pharmaceutical Industries, Inc.)
FDA approves Sun Pharmaceutical Industries' imiquimod generic under an Original Application (ANDA 200173) for the same indications as the br…
-
FDA approval · 2010-09-07FDA Approved: IMIQUIMOD — Original Application (Padagis Israel Pharmaceuticals Ltd)
The FDA approved Padagis Israel Pharmaceuticals Ltd's imiquimod generic (ANDA 078837) for actinic keratosis, superficial basal cell carcinom…